Nipocalimab bei generalisierter Myasthenia gravis zugelassen

NeuroTransmitter 2026

View at publisher
Authors: Redaktion Facharztmagazine
DOI: 10.1007/s15016-025-4183-9
Cited by: 0

Fields of Study & Subjects

Myasthenia Gravis and Thymoma Peripheral Neuropathies and Disorders Autoimmune Neurological Disorders and Treatments

Publication details

Journal / source
NeuroTransmitter
Volume
37
Issue
1
Pages
67–67
Publication date
1 February 2026
Language
DE